NCT06799273View on ClinicalTrials.gov

MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis

RecruitingOBSERVATIONAL

Enrollment

1,400

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions

Cardiac Amyloidosis

Trial Locations (1)

20138

RECRUITING

Centro Cardiologico Monzino, Irccs, Milan

All Listed Sponsors

lead

Centro Cardiologico Monzino

OTHER